Business Operations Contracts & Agreements in the Life Sciences Tools & Services Industry

302 Contracts & Agreements

Browse by Subcategory

Advisory Agreements (3 contracts from 3 companies)
Agency Agreements (13 | 6)
Collaboration Agreements (26 | 13)
Development Agreements (19 | 12)
Distribution Agreements (3 | 3)
Indemnification Agreements (53 | 41)
Management Agreements (18 | 7)
Marketing Agreements (4 | 3)
MOUs (6 | 1)
Proxy Agreements (1 | 1)
Sales Agreements (12 | 8)
Services Agreements (45 | 20)
Settlement Agreements (18 | 11)
Supply Agreements (61 | 13)
Termination Agreements (10 | 8)
Voting Agreements (10 | 5)

Browse by Company

Recent Contracts

Form of Indemnification Agreement entered into by and between Standard BioTools Inc. and certain of its officers and directors (FLUIDIGM CORP, Filed With SEC on March 1, 2024)
Sales Agreement, dated as of February 28, 2024, between Nautilus Biotechnology, Inc. and Cowen and Company, LLC (ARYA Sciences Acquisition Corp III, Filed With SEC on February 28, 2024)
Third Amendment to Collaboration Agreement, dated September 21, 2023, among SomaLogic, Inc., Illumina Cambridge, Ltd., and Illumina, Inc (CM Life Sciences II Inc., Filed With SEC on November 8, 2023)
Third Amendment to Collaboration Agreement, dated as of October 27, 2023, by and between 23andMe, Inc. and GlaxoSmithKline Intellectual Property (No. 3) Limited (VG Acquisition Corp., Filed With SEC on November 8, 2023)
Ninth Amendment to Manufacturing and Supply Agreement, dated as of November 2, 2023, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on November 8, 2023)
First Amendment to the Amended and Restated Supply Agreement, dated August 16, 2023, by and between the Company, Nestec Ltd. and NHSc (ChromaDex Corp., Filed With SEC on November 8, 2023)
Form of Warrant Agency Agreement between SeqLL Inc. and Vstock Transfer LLC including form of warrant certificate (SeqLL, Inc., Filed With SEC on November 7, 2023)
Form of Warrant Agency Agreement between SeqLL Inc. and VStock Transfer LLC including form of warrant certificate (SeqLL, Inc., Filed With SEC on October 18, 2023)
Form of Warrant Agency Agreement between SeqLL Inc. and VStock Transfer LLC including form of warrant certificate (SeqLL, Inc., Filed With SEC on October 5, 2023)
Form of Warrant Agency Agreement between SeqLL Inc. and VStock Transfer LLC including form of warrant certificate (SeqLL, Inc., Filed With SEC on August 15, 2023)
Second Amendment to Supply Agreement, dated April 11, 2023, between SomaLogic, Inc. and Agilent Technologies, Inc (CM Life Sciences II Inc., Filed With SEC on August 14, 2023)
Second Amendment to Collaboration Agreement, dated June 15, 2023, among SomaLogic, Inc., Illumina Cambridge, Ltd. and Illumina, Inc (CM Life Sciences II Inc., Filed With SEC on June 22, 2023)
Sales Agreement, dated June 16, 2023, by and between Absci Corporation and Cowen and Company, LLC (AbSci Corp, Filed With SEC on June 16, 2023)
Amendment No. 1 to Sales Agreement, dated March 9, 2023, by and between the Company and Cowen and Company, LLC (BioNano Genomics, Inc, Filed With SEC on May 9, 2023)
Amendment No. 3 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals (CODEXIS INC, Filed With SEC on May 4, 2023)
Settlement Agreement (Sotera Health Co, Filed With SEC on May 3, 2023)
First Amendment to Collaboration Agreement, dated November 14, 2022, among SomaLogic, Inc., Illumina Cambridge, Ltd. and Illumina, Inc (CM Life Sciences II Inc., Filed With SEC on March 28, 2023)
Protein Engineering Collaboration Agreement, dated as of March 13, 2023, by and between Quantum-Si Incorporated and Protein Evolution, Inc (HighCape Capital Acquisition Corp., Filed With SEC on March 17, 2023)
Advisory Agreement, dated as of November 1, 2022, by and between Quantum-Si Incorporated and Jonathan M. Rothberg, Ph.D (HighCape Capital Acquisition Corp., Filed With SEC on March 17, 2023)
Eighth Amendment to Manufacturing and Supply Agreement, dated as of December 14, 2022, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on March 8, 2023)
Form of Amendment to Senior Management Agreement (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 28, 2023)
Amendment No. 2 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, effective as of February 1, 2023 (CODEXIS INC, Filed With SEC on February 27, 2023)
Amendment No. 1 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, effective as of December 19, 2022 (CODEXIS INC, Filed With SEC on February 27, 2023)
Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, dated as of July 14, 2022 (CODEXIS INC, Filed With SEC on February 27, 2023)
Form of Indemnification Agreement between the Company and each of its directors, officers and certain employees (CODEXIS INC, Filed With SEC on February 27, 2023)
Placement Agency Agreement dated as of February 13, 2023 between SeqLL Inc. and Maxim Group LLC (SeqLL, Inc., Filed With SEC on February 15, 2023)
Amendment No. 2 to Master Collaboration Agreement, dated as of January 4, 2023, by and between SomaLogic Operating Co., Inc. and Novartis Pharma AG (CM Life Sciences II Inc., Filed With SEC on January 10, 2023)
Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals (CODEXIS INC, Filed With SEC on November 4, 2022)
Termination and Release Agreement (ChromaDex Corp., Filed With SEC on October 3, 2022)
Amended and Restated Development and Commercialization Agreement by and between the Registrant and Invitae Corporation dated June 24, 2022 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on August 8, 2022)
Form of Indemnification and Advancement Agreement (Syneos Health, Filed With SEC on August 2, 2022)
Settlement Agreement, dated as of July 11, 2022, by and between Inivata Limited and Clive Morris (NEOGENOMICS INC, Filed With SEC on July 18, 2022)
Amendment to Settlement Agreement between the Company and Geneva Roth Remark Holdings, Inc., dated April 19, 2022 (Bio-Matrix Scientific Group, Inc., Filed With SEC on May 18, 2022)
Settlement Agreement between the Company and Geneva Roth Remark Holdings, Inc., dated February 8, 2022 (Bio-Matrix Scientific Group, Inc., Filed With SEC on May 18, 2022)
Joint Ownership Management Agreement, effective October 9, 2015, between Queens University of Belfast and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on May 12, 2022)
First Amendment to the Joint Ownership Management Agreement, effective March 9, 2022, between Queens University of Belfast and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on May 12, 2022)
Supply Agreement, dated August 15, 2017, between SomaLogic, Inc. and Global Life Sciences Solutions USA LLC, as amended by that certain First Amendment to Catalog Product Support... (CM Life Sciences II Inc., Filed With SEC on March 29, 2022)
Supply Agreement, dated April 8, 2019, between SomaLogic, Inc. and Agilent Technologies, Inc., as amended by that certain First Amendment to Supply Agreement, dated October 1,... (CM Life Sciences II Inc., Filed With SEC on March 29, 2022)
Research Collaboration and License Agreement by and between Registrant and Pfizer Inc. dated December 20, 2021 (Codex DNA, Inc., Filed With SEC on March 23, 2022)
Supply Agreement, dated December 19, 2018, by and between ChromaDex, Inc. and Nestec Ltd. * v (ChromaDex Corp., Filed With SEC on March 14, 2022)